Decreased Coagulability Has No Clinically Relevant Effect on Atherogenesis
نویسندگان
چکیده
منابع مشابه
Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency.
BACKGROUND Hemostasis affects ischemic cardiovascular disease through its role in formation of occluding arterial thrombi. Several studies suggest that hemostasis also might play a role in atherogenesis. We investigated whether individuals with an inherited bleeding tendency are protected against development of atherosclerosis. METHODS AND RESULTS A total of 76 individuals with an inherited b...
متن کاملDarifenacin Has No Clinically Relevant Effect on Warfarin or Digoxin Pharmacodynamics/kinetics in Healthy Males
Darifenacin is a muscarinic M3 selective receptor antagonist developed for the treatment of overactive bladder (OAB). OAB is common in older patients, who may also receive warfarin or digoxin. As darifenacin is a substrate for cytochrome P450 (CYP) enzymes 2D6 and 3A4, and for the p-glycoprotein pump (p-gp) (Skerjanec et al., 2004), interactions with other substrates such as warfarin (CYP3A4) a...
متن کاملPalbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer
The aim of this study was to assess the potential effects of palbociclib in combination with letrozole on QTc. PALOMA-2, a phase 3, randomized, double-blind, placebo-controlled trial, compared palbociclib plus letrozole with placebo plus letrozole in postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. The study included...
متن کاملThe prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.
The present clinical trial was designed to evaluate the possible pharmacokinetic and electrocardiographic interactions of the gastroenteric prokinetic drug cinitapride with ketoconazole. The safety and tolerability of the study treatments were also evaluated. After a placebo-controlled, double-blind, crossover design, 16 healthy male (n = 8) and female (n = 8) volunteers were randomized into fo...
متن کاملValerian: No Evidence for Clinically Relevant Interactions
In recent popular publications as well as in widely used information websites directed to cancer patients, valerian is claimed to have a potential of adverse interactions with anticancer drugs. This questions its use as a safe replacement for, for example, benzodiazepines. A review on the interaction potential of preparations from valerian root (Valeriana officinalis L. root) was therefore cond...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2001
ISSN: 0009-7322,1524-4539
DOI: 10.1161/hc3501.094232